Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Zuris

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biochemistry|October 2, 2009
Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug bindingDaniel W Bak, John A Zuris, Mark L Paddock, et al.
Nature Chemical Biology|April 8, 2015
Small molecule-triggered Cas9 protein with improved genome-editing specificityKevin M Davis, Vikram Pattanayak, David B Thompson, et al.
Nature|April 21, 2016
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageAlexis C Komor, Yongjoo B Kim, Michael S Packer, et al.
The Journal of Biological Chemistry|February 22, 2012
NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor proteinJohn A Zuris, Syed S Ali, Howard Yeh, et al.
Journal of the American Chemical Society|September 4, 2010
Engineering the redox potential over a wide range within a new class of FeS proteinsJohn A Zuris, Danny A Halim, Andrea R Conlan, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 4, 2011
Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environmentAndrea R Conlan, Mark L Paddock, Christina Homer, et al.
The CRISPR Journal|June 26, 2020
Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T CellsAnne Bothmer, Kenneth W Gareau, Hayat S Abdulkerim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticlesMing Wang, John A Zuris, Fantao Meng, et al.
Plos One|May 30, 2013
Nutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugsSagi Tamir, John A Zuris, Lily Agranat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2012
Allosteric control in a metalloprotein dramatically alters functionElizabeth Leigh Baxter, John A Zuris, Charles Wang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biochemistry|October 2, 2009
Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug bindingDaniel W Bak, John A Zuris, Mark L Paddock, et al.
Nature Chemical Biology|April 8, 2015
Small molecule-triggered Cas9 protein with improved genome-editing specificityKevin M Davis, Vikram Pattanayak, David B Thompson, et al.
Nature|April 21, 2016
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageAlexis C Komor, Yongjoo B Kim, Michael S Packer, et al.
The Journal of Biological Chemistry|February 22, 2012
NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor proteinJohn A Zuris, Syed S Ali, Howard Yeh, et al.
Journal of the American Chemical Society|September 4, 2010
Engineering the redox potential over a wide range within a new class of FeS proteinsJohn A Zuris, Danny A Halim, Andrea R Conlan, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 4, 2011
Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environmentAndrea R Conlan, Mark L Paddock, Christina Homer, et al.
The CRISPR Journal|June 26, 2020
Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T CellsAnne Bothmer, Kenneth W Gareau, Hayat S Abdulkerim, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticlesMing Wang, John A Zuris, Fantao Meng, et al.
Plos One|May 30, 2013
Nutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugsSagi Tamir, John A Zuris, Lily Agranat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2012
Allosteric control in a metalloprotein dramatically alters functionElizabeth Leigh Baxter, John A Zuris, Charles Wang, et al.
Pageof 3